Rise in GP numbers must be ‘sustained and accelerated’, says RCGP
The latest GP workforce figures show a small rise in numbers, which the Royal College of General Practitioners (RCGP) says must be “sustained and accelerated”.
25th November 2018
Latest news
Oxford BioMedica unveils digital initiative to streamline manufacturing
UK gene and cell therapy group Oxford BioMedica has announced a new digital framework initiative to streamline the production of next-generation medicines.
25th November 2018
EU OKs Novartis’ gene therapy Luxturna for rare retinal disease
Novartis’ Luxturna has been approved by regulators in Europe to treat a rare inherited condition that causes sight loss.
25th November 2018
Pharma agrees to 2% cap on branded meds growth
The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
25th November 2018
The PharmaTimes International Clinical Researcher of the Year is open for entry – with a broad range of categories for all types of candidates
There is a category for everyone at all levels of experience in this year’s 20th anniversary edition of the PharmaTimes International Clinical Researcher of the Year 2019.
23rd November 2018
Social media use more common in young with mental disorders, research shows
Nearly 13 percent of children and young people aged between five and 19 years had a mental disorder in 2017, according to a major new report by NHS Digital.
23rd November 2018
Type II diabetes now affects 7,000 under-25's in England and Wales
Nearly 7,000 children and young adults in England and Wales now have type II diabetes, as the rise in obesity continues, Diabetes UK has warned.
23rd November 2018
Lords ask Minister for clarity on access to medicine after Brexit
The House of Lords EU Home Affairs Sub-Committee has written to health secretary Matt Hancock asking for clarity on the government’s contingency preparations to ensure the UK has continued access to medicines and medical products in the event of a ‘no deal’ Brexit.
23rd November 2018
Gov’t announces £3.5bn a year for primary, community care
The government has announced plans to inject an extra £3.5 billion a year into primary and community healthcare by 2023/24, calling the investment a “historic commitment” to increasing the proportion of NHS funding spent on primary and community services.
23rd November 2018
Pennsylvania Uni brings Penn Medicine to London
Penn Medicine has launched its first European presence in London, in a move that aims to expand access to innovations pioneered by its physicians in the US to patients in the UK and Europe.
23rd November 2018
MAGI partnering with PharmaTimes for the 2019 Clinical Researcher of the Year - The Americas
PharmaTimes are pleased to announce we will be partnering with MAGI to bring the Clinical Researcher of the Year competition to new audiences in the Americas.
22nd November 2018
Thousands of lung cancer patients to get NHS access to Keytruda
MSD’s Keytruda should be funded on the NHS via the Cancer Drugs Fund for patients with the certain forms of lung cancer, according to draft guidance from the National Institute for Health and Care Excellence.
22nd November 2018
Pharmacists still under-used as 'unnecessary' GP appointments hit 13.5m
Over a quarter of UK pharmacists still don’t believe their skills are being properly utilised by the public, and just 5% think the UK public are aware of the level of expertise that they have, new research shows.
22nd November 2018
One in three COPD patients believe they would get better care with different disease
One third of patients with chronic obstructive pulmonary disease (COPD) feel they would receive better care if they had cancer, diabetes or heart disease, according to a new Chiesi-sponsored patient survey.
22nd November 2018
UK’s cell and gene therapy industry continues to strengthen
The UK’s cell and gene therapy industry has seen a 60% increase in manufacturing space in the last year, new research published by the Cell and Gene Therapy (CGT) Catapult has revealed.
22nd November 2018
